Related Experiment Video
Updated: Jul 6, 2026
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Contraception Requirements in Early Clinical Trials: Considerations Towards an Evidence-Based Approach
1ICON plc, Consulting and Advisory Services, Berlin, Germany. tatyana.dubich@iconplc.com.
Pharmaceutical Medicine
|February 22, 2025
Summary
Contraception requirements in clinical trials vary widely. A holistic, risk-based approach is needed to balance embryo safety with participant burden and contraceptive risks.
Area of Science:
- Clinical Pharmacology
- Drug Development
- Reproductive Health
Background:
- Women of childbearing potential are crucial for clinical trial data.
- Unintended pregnancies pose risks to embryo development.
- Current contraception requirements in trials lack standardization.
Purpose of the Study:
- To review risks associated with contraception requirements in clinical trials.
- To critically evaluate the 'worst-case' risk assessment approach.
- To propose a holistic, risk-based strategy for managing contraception in trials.
Main Methods:
- Literature review of contraception requirements in clinical trials.
- Analysis of risks and benefits of various risk mitigation strategies.
- Evaluation of hormonal contraceptive use and subject burden.
Main Results:
- Contraception requirements differ significantly across sponsors and trials.
- The 'worst-case' approach may lead to overly strict precautions.
- A balanced approach is needed to consider all relevant data.
Conclusions:
- Standardized, risk-based contraception strategies are essential for clinical trials.
- Holistic approaches should weigh embryo safety against participant burden and contraceptive side effects.
- Further research into optimized risk mitigation is warranted.
More Related Videos
Related Concept Videos
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:11Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:22Birth Control Methods
161
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
161
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
01:12Hazard Ratio
77
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
77